International Business Machines Corporation

Merative US L.p.

Elinor Dehan

Claudia S Huettner

Vanessa V Michelini

Cheryl L Eifert

Jia Xu

Fang Wang

Kirk Alan Beaty

Bhuvan Sharma

Marta Sanchez-Martin

Shang Xue

Himanshu Sharma

A mechanism is provided for processing electronic files to identify genetic variants of a gene. Evidence of one or more genetic variants of the gene and corresponding information is extracted from a corpus of information. Each genetic variant of the one or more genetic variants is classified based on whether the genetic variant is identified as being pathogenic. Genetic variant annotation is then performed to generate a summary.

Automatic processing of electronic files to identify genetic variants

Computer based methods, systems, and computer readable media are provided for intelligently sorting cells using machine learning. A biological cell analysis sorting machine, wherein the biological cell analysis sorting machine comprises a flow cytometry system and a cell analytics sorting system, may be configured to detect configuration issues by analyzing results of a sorting experiment performed by the biological cell analysis sorting machine. An analysis of a history of prior sorting experiments and associated configuration settings may be performed and a corpus of documents pertaining to the sorting experiment based on the detected configuration issues may be analyzed. Updated configuration settings for the biological cell analysis sorting machine based on the performed analysis may be determined, and the biological cell analysis sorting machine may be configured with the updated configuration settings to conduct a desired sorting experiment.

Automated configuration of flow cytometry machines

Computer based methods, systems, and computer readable media for intelligently accessing various types of pharmaceutical information in a content repository and ranking drugs at the variant level, gene level, and pathway level. In some cases, drugs that target the same gene, gene variant, or biological pathway may be ranked based upon in vitro, pre-clinical, clinical, or post-clinical evidence. To determine ranking of a plurality of drugs, information pertaining to drug administration is analyzed for the drugs. For a plurality of drugs, attributes corresponding to the drug are determined, wherein the attributes include a variant or a gene targeted by the drug, and a biological pathway comprising the targeted variant or gene. The plurality of drugs are ranked according to a drug effectiveness score based on one or more of a determined efficacy, potency, or toxicity.

Determining drug effectiveness ranking for a patient using machine learning

Growing community of inventors

Haniel, Israel

Elinor Dehan